AC Camargo Cancer Center

São Paulo, 01509-001

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Natasha Carvalho

Mauro DS Donadio

Rachel SP Riechelmann

Marcelle G Cesca

Open studies

Colorectal cancer

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - Amgen

Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer - Metronidazole - Conselho Nacional de Desenvolvimento Científico e Tecnólogico - CNPQ

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer - OrigAMI-2 - Janssen Research & Development, LLC

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy - OrigAMI-3 - Janssen Research & Development, LLC

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery - POSBIO-CRC - AC Camargo Cancer Center

Breast Cancer

Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer - HER2Cell - AC Camargo Cancer Center

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and Company

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) - PRESERVE - Sunnybrook Health Sciences Centre

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - ELEGANT - Stemline Therapeutics, Inc.

Lung cancer

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer - PALOMA-2 - Janssen Research & Development, LLC

A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) - Amgen

Carcinoid Syndrome

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Carcinoid tumor

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Cervical cancer

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer - Nivolumab - Hospital Israelita Albert Einstein

Chondrosarcoma

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - CHONQUER - Servier Bio-Innovation LLC

Gastrointestinal Cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Gastrointestinal stromal tumors

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib - INSIGHT - Deciphera Pharmaceuticals LLC

Head and neck cancer

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone - Boehringer Ingelheim

Liver cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Multiple myeloma

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4 - Janssen Pharmaceutica

Neuroendocrine tumor

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer Center

Neuroendocrine Tumor

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer Center

Non-Hodgkin Lymphoma

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - Celgene

Ovarian cancer

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention - TUBA-WISP-II - University Medical Center Nijmegen

Pancreatic cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Solid tumors

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

AC Camargo Cancer Center

São Paulo, 01509-001

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Natasha Carvalho

Mauro DS Donadio

Rachel SP Riechelmann

Marcelle G Cesca

Open studies

Colorectal cancer

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery - POSBIO-CRC - AC Camargo Cancer Center

Breast Cancer

Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer - HER2Cell - AC Camargo Cancer Center

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and Company

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) - PRESERVE - Sunnybrook Health Sciences Centre

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - ELEGANT - Stemline Therapeutics, Inc.

Lung cancer

A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) - Amgen

Carcinoid Syndrome

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Carcinoid tumor

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Cervical cancer

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer - Nivolumab - Hospital Israelita Albert Einstein

Chondrosarcoma

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - CHONQUER - Servier Bio-Innovation LLC

Gastrointestinal Cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Gastrointestinal stromal tumors

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib - INSIGHT - Deciphera Pharmaceuticals LLC

Head and neck cancer

Liver cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Multiple myeloma

Neuroendocrine tumor

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer Center

Neuroendocrine Tumor

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer Center

Non-Hodgkin Lymphoma

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - Celgene

Ovarian cancer

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention - TUBA-WISP-II - University Medical Center Nijmegen

Pancreatic cancer

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.

Solid tumors

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads